Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,438 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $319.44 | 16 | $0 (2024) |
| Eisai Inc. | $182.30 | 5 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $179.60 | 6 | $0 (2024) |
| Lilly USA, LLC | $122.50 | 1 | $0 (2022) |
| Radius Health, Inc. | $115.29 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $107.24 | 7 | $0 (2024) |
| Amgen Inc. | $99.19 | 5 | $0 (2024) |
| Kyowa Kirin, Inc. | $62.82 | 3 | $0 (2023) |
| ARGENX US, INC. | $55.82 | 2 | $0 (2024) |
| Lundbeck LLC | $46.23 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $667.40 | 30 | ABBVIE INC. ($190.19) |
| 2023 | $406.54 | 20 | ABBVIE INC. ($111.55) |
| 2022 | $330.37 | 8 | Lilly USA, LLC ($122.50) |
| 2021 | $33.91 | 2 | Avanir Pharmaceuticals, Inc. ($17.41) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Neurology | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Rare Disease | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Neurology | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Rare Disease | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Neurology | ||||||
| 08/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Rare Disease | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: Neurology | ||||||
| 06/26/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: EPILEPSY | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Neurology | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Neurology | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $86.13 | General |
| Category: Neurology | ||||||
| 04/04/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 04/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 212 | 243 | $75,389 | $16,888 |
| 2022 | 2 | 167 | 177 | $56,843 | $13,015 |
| 2021 | 2 | 137 | 154 | $45,156 | $11,263 |
| 2020 | 1 | 21 | 21 | $3,738 | $1,088 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 125 | 125 | $46,125 | $10,238 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 87 | 118 | $29,264 | $6,650 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 107 | 107 | $39,483 | $8,800 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 60 | 70 | $17,360 | $4,215 | 24.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 79 | 79 | $27,886 | $6,859 | 24.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 58 | 75 | $17,270 | $4,404 | 25.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 21 | 21 | $3,738 | $1,088 | 29.1% |
About Amy Sullivan, NP
Amy Sullivan, NP is a Nurse Practitioner healthcare provider based in Newburgh, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2020. The National Provider Identifier (NPI) number assigned to this provider is 1275145369.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Sullivan, NP has received a total of $1,438 in payments from pharmaceutical and medical device companies, with $667.40 received in 2024. These payments were reported across 60 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,438).
As a Medicare-enrolled provider, Sullivan has provided services to 537 Medicare beneficiaries, totaling 595 services with total Medicare billing of $42,253. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Newburgh, IN
- Active Since 08/19/2020
- Last Updated 10/06/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1275145369
Products in Payments
- BOTOX (Biological) $195.45
- Leqembi (Drug) $182.30
- ULTOMIRIS (Biological) $145.55
- UBRELVY (Drug) $123.99
- Tymlos (Drug) $92.04
- EVENITY (Biological) $70.71
- KESIMPTA (Drug) $62.95
- Crysvita (Drug) $62.82
- VYVGART HYTRULO (Drug) $55.82
- VYEPTI (Biological) $46.23
- LEQVIO (Drug) $44.29
- Nuedexta (Drug) $36.69
- VNS Therapy SenTiva Model 1000 Generator (Device) $35.08
- Repatha (Biological) $28.48
- LINQ II (Device) $23.23
- ELIQUIS (Drug) $19.73
- VALTOCO (Drug) $18.15
- ANDEXXA (Biological) $14.91
- STRENSIQ (Biological) $14.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Newburgh
Amy Stott, Np, NP
Nurse Practitioner — Payments: $6,283
Jenna Rickenbaugh, Np, NP
Nurse Practitioner — Payments: $5,063
Danielle Mcfadden, Np, NP
Nurse Practitioner — Payments: $4,982
Lauren Tillman, Apn, Cnp, APN, CNP
Nurse Practitioner — Payments: $4,470
Kelsey Sammet
Nurse Practitioner — Payments: $3,215
Mrs. Alice Looney, Anpbc, ANPBC
Nurse Practitioner — Payments: $2,940